A Breakthrough in Treatment

FLEX VESSEL PREP™ SYSTEM

Arteriovenous Access
Maintain Access for Dialysis

OPTIMIZE PTA IN AV ACCESS MANAGEMENT

PROBLEM: PTA has significant limitations

  • Balloons can rupture the neointimal layer causing explosive injury in the vessel which may lead to diminished outcomes for patients

  • Elastic recoil

  • Resistant hyperplasia – even with ultra high-pressure balloons

SOLUTION: FLEX was designed to

  • Improves vessel compliance

  • Enable lower uniform balloon inflation pressures

  • Minimizes barotrauma that may extend primary patency or time to reintervention

  • Treat single target or multiple stenoses including difficult Cephalic Arch stenoses In the AV circuit with one device

Peripheral Arterial Disease
Obstructed Blood Flow in Legs

THE SAME UNIQUE MECHANISM OF ACTION WORKS IN PAD

PROBLEM: Long, mixed-morphology lesions are challenging to treat

  • 40-50% of treatment sites restenose within 12 months

  • Other vessel prep technologies may cause complications:

    • Severe dissection
    • Performation,
    • Embolization

SOLUTION: FLEX was designed to

  • Improve vessel compliance and luminal gain

  • Reduce extent and severity of dissections

  • Reduce rate of restenosis & treat in-stent restenosis

  • Facilitate drug transfer and retention

A Breakthrough in Treatment

FLEX VESSEL PREP™ SYSTEM

Arteriovenous Access
Maintain Access for Dialysis

OPTIMIZE PTA IN AV ACCESS MANAGEMENT

PROBLEM: PTA has significant limitations

  • Balloons can rupture the neointimal layer causing explosive injury in the vessel which may lead to diminished outcomes for patients

  • Elastic recoil

  • Resistant hyperplasia – even with ultra high-pressure balloons

SOLUTION: FLEX was designed to

  • Improves vessel compliance

  • Enable lower uniform balloon inflation pressures

  • Minimizes barotrauma that may extend primary patency or time to reintervention

  • Treat single target or multiple stenoses including difficult Cephalic Arch stenoses In the AV circuit with one device

Peripheral Arterial Disease
Obstructed Blood Flow in Legs

THE SAME UNIQUE MECHANISM OF ACTION WORKS IN PAD

PROBLEM: Long, mixed-morphology lesions are challenging to treat

  • 40-50% of treatment sites restenose within 12 months

  • Other vessel prep technologies may cause complications:

    • Severe dissection
    • Performation,
    • Embolization

SOLUTION: FLEX was designed to

  • Improve vessel compliance and luminal gain

  • Reduce extent and severity of dissections

  • Reduce rate of restenosis & treat in-stent restenosis

  • Facilitate drug transfer and retention

FLEX DYNAMIC TREATMENT TECHNOLOGY

Dynamic Engagement

Intuitive, retrograde pullback enables continuous engagement of the dynamic treatment element (TE) along entire length of any lesion

Micro-incision Creation

Precise surgical blades create controlled-depth, continuous micro-incisions in real-world morphologies

AV Stenosis/Plaque Modification

Incising the stenosis/plaque disrupts the circumferential tension in diseased vessels to enable luminal gain with improved vessel compliance and reduced vessel trauma/complications

Learn About The Device Specifications

FLEX DYNAMIC TREATMENT TECHNOLOGY

Dynamic Engagement

Intuitive, retrograde pullback enables continuous engagement of the dynamic treatment element (TE) along entire length of any lesion

Micro-incision Creation

Precise surgical blades create controlled-depth, continuous micro-incisions in real-world morphologies

AV Stenosis/Plaque Modification

Incising the stenosis/plaque disrupts the circumferential tension in diseased vessels to enable luminal gain with improved vessel compliance and reduced vessel trauma/complications

Learn About The Device Specifications

Extending Patency is The Goal

IMPROVING LONG + SHORT-TERM OUTCOMES

Physicians are looking for better options to treat patients with stenosed AV fistulas and grafts and PAD. Successful treatment includes three steps: Crossing, Balloon pre-treatment and delivery of final therapy, while avoiding the traditional complications of PTA and stents.

FLEX Vessel PrepTM System provides controlled stenosis/plaque modification to: 

Improve Vessel Compliance

Minimize Vessel Damage and Trauma

Improve Final Therapy Delivery

Learn More About Treatment
Extending Patency is The Goal

IMPROVING LONG + SHORT-TERM OUTCOMES

Physicians are looking for better options to treat patients with stenosed AV fistulas and grafts and PAD. Successful treatment includes three steps: Crossing, Balloon pre-treatment and delivery of final therapy, while avoiding the traditional complications of PTA and stents.

FLEX Vessel PrepTM System provides controlled stenosis/plaque modification to: 

Improve Vessel Compliance
Minimize Vessel Damage and Trauma
Improve Final Therapy Delivery
Learn More About Treatment

We’re Changing the Game in

AV ACCESS MANAGEMENT + PERIPHERAL REVASCULARIZATION

At VentureMed we believe:

  • Enabling better outcomes for patients is job #1

  • Stenosis and plaque modification is paramount to enabling consistent, sustained outcomes

  • Simplicity is the wave of the future in AV Access and PAD treatment

  • Physicians need safe and effective, easy-to-use devices that can help reduce procedure times

  • Hospitals and payers need cost-effective options to help keep healthcare costs lower

Explore FLEX FIRST
“When you first start off trying to solve a problem, the first solutions you come up with are very complex, and most people stop there. But if you keep going and live with the problem and peel more layers of the onion off, you can often times arrive at some very elegant and simple solutions.”

– Steve Jobs

We’re Changing the Game in

AV ACCESS MANAGEMENT + PERIPHERAL REVASCULARIZATION

At VentureMed we believe:

  • Enabling better outcomes for patients is job #1

  • Stenosis and plaque modification is paramount to enabling consistent, sustained outcomes

  • Simplicity is the wave of the future in AV Access and PAD treatment

  • Physicians need safe and effective, easy-to-use devices that can help reduce procedure times

  • Hospitals and payers need cost-effective options to help keep healthcare costs lower

Explore FLEX FIRST
“When you first start off trying to solve a problem, the first solutions you come up with are very complex, and most people stop there. But if you keep going and live with the problem and peel more layers of the onion off, you can often times arrive at some very elegant and simple solutions.”

– Steve Jobs

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.

VentureMed Group, Inc. is a member of Medical Alley

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.

VentureMed Group, Inc. is a member of Medical Alley